Bovine Leukemia virus titer and leukocyte population associated with mastitis in periparturient

Similar documents
ENVIRACOR J-5 aids in the control of clinical signs associated with Escherichia coli (E. coli) mastitis

MATERIALS AND METHODS

Title. Author(s)WANG, Chun-Tshen. CitationJapanese Journal of Veterinary Research, 39(2-4): 10. Issue Date DOI. Doc URL.

Transition cows have decreased immune function. The transition period. Inflammation, Immune Function, and the Transition Cow.

BLV BLV. bovine leukosis leukemia BLV, BLV. Vernau. QIAmp DNeasy Blood.

Mastitis: Background, Management and Control

Lactation. Macroscopic Anatomy of the Mammary Gland. Anatomy AS 1124

BOVINE LEUKEMIA VIRUS: THE SILENT THIEF

Walter M. Guterbock, DVM, MS Veterinary Medicine Teaching and Research Center University of California, Davis

Presented at Central Veterinary Conference, Kansas City, MO, August 2013; Copyright 2013, P.L Ruegg, all rights reserved

Prevalence of Bovine Leukemia Virus in Young, Purebred Beef Bulls for Sale in Kansas

New Developments in Mastitis Research

MASTITIS. Therefore, mastitis is an inflammation of the mammary gland.

Lactoferrin Concentrations in Milk from Normal and Subclinical Mastitic Cows

Dairy Calf, BVDv-PI Dead & Chronic Monitoring Program

Use of a novel adjuvant to enhance the antibody response to vaccination against Staphylococcus aureus mastitis in dairy heifers.

Enzootic Bovine Leukosis: Milk Screening and Verification ELISA: VF-P02210 & VF-P02220

Milk quality & mastitis - troubleshooting, control program

Differential Somatic Cell Count with the Fossomatic 7 DC - a novel parameter

Subclinical mastitis in small ruminants: prevalence, comparative aspects and prevention

Using SCC to Evaluate Subclinical Mastitis Cows

The surveillance and control programme for enzootic bovine leukosis (EBL) in Norway

Strep. ag.-infected Dairy Cows

Interpretation and Use of Laboratory Culture Results and the Characteristics of Various Mastitis Pathogens

Mastitis MANAGING SOMATIC CELLS COUNTS IN. Somatic Cell Count Are Affected by. Somatic Cells are NOT Affected by:

Caused by microorganisms (usually bacteria) that invade the udder, multiply, and produce toxins that are harmful to the mammary gland

Minna Koivula & Esa Mäntysaari, MTT Agrifood Research Finland, Animal Production Research, Jokioinen, Finland

Bovine Leukemia Virus Infection in Dairy Cows in Egypt

Transition Period 1/25/2016. Energy Demand Measured glucose supply vs. estimated demands 1

MASTITIS CASE MANAGEMENT

2012 Indiana Regional Dairy Meetings. Purdue University College of Veterinary Medicine Dr. Jon Townsend Dairy Production Medicine

Long influence of Escherichia coli intramammary infections on milk quality

Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. II. Field trial

Economic Review of Transition Cow Management

, Pamela L. Ruegg

MILK COMPOSITIONAL CHANGES DURING MASTITIS

Controlling Contagious Mastitis

CURRENT STATUS AND FUTURE CHALLENGES IN MASTITIS RESEARCH

Dr. Michelle Arnold, DVM DABVP (Food Animal) Ruminant Extension Veterinarian University of Kentucky Veterinary Diagnostic Laboratory

Prototheca Mastitis in Dairy Cows

Milking behaviour in dairy cows naturally infected with clinical mastitis

Interpretation and Use of Laboratory Culture Results and the Characteristics of Various Mastitis Pathogens

Dairy/Milk Testing Report Detecting Elevated Levels of Bacteria in Milk-On-Site Direct- From-The-Cow Within Minutes as Indicator of Mastitis

S. P. Oliver, R. A. Almeida, B. E. Gillespie, S. J. Ivey, H. Moorehead, P. Lunn, H. H. Dowlen, D. L. Johnson, and K. C. Lamar

Case Study: Dairy farm reaps benefits from milk analysis technology

Prevalence of sub clinical mastitis in small holder dairy farms in Selale, North Shewa Zone, Central Ethiopia

Veterinaria.com.pt 2009; Vol. 1 Nº 1: e13 (publicação inicial em Julho de 2008) Disponível em

Mastitis Reminders and Resources LAURA SIEGLE EXTENSION AGENT VIRGINIA COOPERATIVE EXTENSION AMELIA COUNTY

University of Missouri Extension Using the California Mastitis Test

Vaccination Strategies for Mastitis

April Boll Iowa State University. Leo L. Timms Iowa State University. Recommended Citation

Premiums, Production and Pails of Discarded Milk How Much Money Does Mastitis Cost You? Pamela Ruegg, DVM, MPVM University of Wisconsin, Madison

IMMUNOSTIMULATING EFFECTS OF A COMMERCIAL FEED SUPPLEMENT IN DAIRY HEIFERS VACCINATED WITH A STAPHYLOCOCCUS AUREUS BACTERIN VALERIE JOANNE EUBANKS

MILK QUALITY PROGRAMS FOR TRANSITION COWS AND HEIFERS. Leo Timms Iowa State University, Ames IA

Milk Quality Management Protocol: Fresh Cows

Practical Biosecurity and Biocontainment on the Ranch. Dale Grotelueschen, DVM, MS Great Plains Veterinary Educational Center Clay Center, NE

The Vital 90 TM Days and Why It s Important to a Successful Lactation

Mastitis Prevention and Cure Rates in Heifers Treated with Spectramast Dry Cow Therapy and/or Orbeseal Dry Cow Teat Sealant

Milk Quality Evaluation Tools for Dairy Farmers

Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and

The organism Infection process Tissue reaction SCC response Prevention Treatment

Using DHIA and bacteriology to investigate herd milk quality problems.

Gina M Pighetti & Raul Almeida. University of Tennessee

Field Efficacy of J-VAC Vaccines in the Prevention of Clinical Coliform Mastitis in Dairy Cattle

Isolation and identification of major causing bacteria from bovinemastitis R. Lakshmi 1 and K.K. Jayavardhanan 2

Last 2-3 months of lactation

Interpretation of Bulk Tank Milk Results

Practical Strategies for Treating Mastitis Pamela L. Ruegg, DVM, MPVM University of Wisconsin, Madison

Genetic parameters for pathogen specific clinical mastitis in Norwegian Red cows

Mastitis control in bred heifers: Use of dry cow therapy and teat sealant for curing existing intramammary infections and preventing new ones

Influence of Experimentally- induced clinical mastitis on Reproductive Performance of Dairy Cattle

Mastitis cows and immunization

LOOKING FOR PROFITS IN MILK QUALITY

Chapter 4: Associations between Specific Bovine Leukocyte Antigen DRB3 alleles and Mastitis in Canadian Holsteins

J. Dairy Sci. 90: doi: /jds American Dairy Science Association, 2007.

Phil s Friendly Filly: Philena. Some Help? Philena the Philly. First Case. Tip: This is abnormal. Quarter horse One-year-old Owner s complaint:

Mature lymphocytosis (ie, 7,000/ L) in the blood of

Decision tree analysis of treatment strategies for mild and moderate cases of clinical mastitis occurring in early lactation

Herd Navigator and mastitis management

The High Plains Dairy Conference does not support one product over another and any mention herein is meant as an example, not an endorsement

Research Article First Report of Bovine Leukemia Virus Infection in Yaks (Bos mutus) in China

Management Practices and Intramammary Infections: New Ideas for an Old Problem

Evaluation of intervention strategies for subclinical and clinical mastitis

Key words: mastitis, dairy, fertility, animal reproduction

Somatic Cell Count as an Indicator of Subclinical Mastitis. Genetic Parameters and Correlations with Clinical Mastitis

Outline MILK QUALITY AND MASTITIS TREATMENTS ON ORGANIC 2/6/12

Interpretation of results from milk samples tested for mastitis bacteria with Mastit 4 qpcr test from DNA Diagnostic

Association between teat skin colonization and intramammary infections with Staphylococcus aureus and Streptococcus agalactiae

EHRLICHIOSIS IN DOGS IMPORTANCE OF TESTING FOR CONTRIBUTING AUTHORS CASE 1: SWIGGLES INTRODUCTION WITH PERSISTENT LYMPHOCYTOSIS

Heifer Mastitis Management Strategies S.C. Nickerson, UGA,

Diurnal variation in microfilaremia in cats experimentally infected with larvae of

Bovine Mastitis: Prevalence and Antibiotic Resistance of Staphylococcus Aureus in Small Holder Herds of Bench Maji Zone, Southern Ethiopia

National Research Center

The surveillance and control programme for enzootic bovine leukosis (EBL) in Norway

Update on Staphylococcus aureus Mastitis. John R. Middleton College of Veterinary Medicine, University of Missouri, Columbia

AN OVERVIEW OF THE LATEST RESEARCH EXAMINING THE IMPACT OF STRESS ON THE HEALTH AND WELFARE OF BEEF CATTLE

Detection of Mastitis

How to Decrease the Use of Antibiotics in Udder Health Management

DeLaval Cell Counter ICC User Strategies Guide

Diseases of Concern: BVD and Trichomoniasis. Robert Mortimer, DVM Russell Daly, DVM Colorado State University South Dakota State University

Transcription:

Bovine Leukemia virus titer and leukocyte population associated with mastitis in periparturient dairy cows Seiichi Kakinuma 1 * Yousuke Maeda 2 Hiromichi Ohtsuka 2 Satoru Konnai 3 Masa-aki Oikawa 2 1 Kakinuma Veterinary Hospital, 200-1 Kodama, Kodama-chou, Honjou, Saitama 367-0212, 2 School of Veterinary Medicine, Kitasato University, Towada, Aomori 034 8628, 3 Department of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan Correspondence to: Seiichi Kakinuma Phone: +81-495-72-0171 Fax: +81-495-72-8244 E-mail: fwid6390@mb.infoweb.ne.jp KEY WORDS: bovine leukemia virus; CD4 +, CD8 + and CD335 + cells; leukocyte population; mastitis; periperturient ABSTRACT We examined the association of postpartum mastitis with virus titer and leukocyte population of Bovine leukemia virus (BLV) infected cows monitoring sixteen BLV infected cows for 3 months after calving. Five cows developed mastitis (Mastitis Group) and 11 cows without mastitis served as a control group (Control Group). Flow cytometric analysis of peripheral blood leukocyte population exhibited higher number of MHC class-ii+cd14- cells in both groups without significant difference between groups. CD3 +, CD4 +, CD8 +, and CD335 + cell numbers in Mastitis Group were lower than the Control Group around the time of calving, but significant difference was observed only for CD335+ cell number. Virus titer in blood significantly increased in Mastitis Group after calving compared to pre-calving titer. These results suggested that lower number of peripheral blood T cells in Mastitis Group cows might have heightened susceptibility to mastitis. In addition, Mastitis Group cows had higher peripheral blood BLV, which might have spread to surroundings. INTRODUCTION Bovine leukemia virus (BLV) belongs to retrovirus family similar to human immunodeficiency virus (HIV) and human T-cell leukemia virus (HTLV). Although BLV infection remains subclinical in the majority of cattle, some cows progress to persistent lymphocytosis (PL) with an expansion of B lymphocytes. Some cows with PL further develop B cell tumor and then enzootic bovine leukosis (EBL). 15,20 Cows with advanced BLV infection showed decreased Intern J Appl Res Vet Med Vol. 12, No. 3, 2014. 239

Table 1. Clinical course and pathogenic bacteria in Mastitis group. Case No. Age Clinical sign Temperature on first examination ( ) Treatment period (days) Pathogenic bacteria Mastitis-1 3.53 Severe 39.8 3 ND Mastitis-2 3.19 Mild 39.0 2 Klebsiella Mastitis-3 6.90 Severe 39.0 3 Streptococcus Mastitis-4 6.80 Mild 39.0 3 Staphylococcus aureus Mastitis-5 5.98 Mild 38.7 9 Yeast Severe : Udder swelling was indurate and unelastic with a little lactation and aorexia. Mild : Udder swelling was elastic and unindurate. ND: Not determined. immune function, thus reduced ability of natural recovery from Trichophyton verrucosum. 4 Dairy cows become susceptible to infectious diseases during the periparturient period due to decreased immune function. 11,19 This periparturient immunosuppression makes BLV infected cows vulnerable to develop EBL and heightens the possibility of virus spreading to other cows by increased peripheral blood virus. 5,16 In addition BLV infected cows in the periparturient period have immunological disturbances with increased peripheral B-cell number. It may further heighten the susceptibility of cows to other infectious diseases. 9,21 BLV infection is speculated to affect mastitis. In fact, BLV was detected in the mammary glands of mastitic cows 23 and BLV infected cows exhibited higher somatic cell counts in milk. 22 Economic losses due to the BLV infection can come from reduced milk production, because the milk yield was higher in healthy cows compared to BLV seropositive cows. 14 There has been no information about the virus titer in the peripheral blood of BLV infected cows during the periparturient period and its association with mastitis development. In this study we examined the virus titer and leukocyte populations in the peripheral blood of BLV infected cows around the time of calving, and their association with clinical mastitis. MATERIALS and METHODS Animals Sixteen healthy Holstein cows positive for BLV by nested-pcr 12 kept at the same farm were used. Among them five cows developed mastitis within 3 months after calving, and they were grouped as Mastitis Group. They were diagnosed by California Mastitis Test (CMT) score and udder swelling. Clinical signs were severe in three cows, and mild in two cows. One cow had high fever on the first medical examination. Milk samples from five cows were kept on sheep blood agar 24 to 48 hours at 37. After incubation, pathogenic bacteria of causing mastitis were identified in four cows (Table1). The remaining 11 were clinically healthy and they were grouped as Control Group. Peripheral blood samples were obtained twice; once within 4 weeks before calving (17.4 +/- 1.6 days before calving, mean +/- sem) and once at 1 to 6 weeks after calving (20.6 +/- 2.0 days after calving). The age of cows at the time of enrollment was 5.3 +/- 0.8 and 4.5 +/- 0.4 years for Mastitis Group and Control Group, respectively. There was no difference in their age. The pre-calving sampling date was 12.0 +/- 3.7 and 19.8 +/- 1.1 days before calving for Mastitis Group and Control Group, respectively. The post-calving sampling was conducted at 23.0 +/- 6.1 and 19.6 +/- 1.2 240 Vol. 12, No.3, 2014 Intern J Appl Res Vet Med.

Table 2. Antibodies used for immunostaining of peripheral blood mononuclear cells. Antigen MAb clone Isotype Specificity Source CD3 MM1A IgG1 Pan T cell VMRD CD4 CACT138A IgG1 Helper/inducer VMRD CD8 BAQ111A IgM Cytotoxic T cell VMRD CD335 MCA2365 IgG1 NK cell AbD WC1-N1 B7A1 IgM γδt-cell VMRD MHC CAT82A IgG1 Class II major VMRD Class II histocompatibility complex CD14 MY4 IgG2b Monocyte Coulter VMRD=VMRD, Inc. (Pullman, WA, U.S.A). Coulter=Becman Coulter (Tokyo, Japan). AbD=AbD Serotec (Oxford, U.K.) The original concentration of the MAb solution was 1 μg/ml. days after calving for Mastitis Group and Control Group, respectively. The history of mastitis treatment in the previous lactation was found in two and one cow, for Mastitis Group and Control Group, respectively. Blood samples were obtained either from the caudal or jugular vein into EDTA-2K and heparin Na containing tubes. BLV Titer BLV titration was conducted by syncytium assay. Peripheral blood mononuclear cells (PBMC) were isolated using Percoll (Amersham Bioscience, U.S.) separation. PBMC (5 x 105) and CC81 cell (1 x 105) were placed into a well in 24-well plate and incubated at 37 o C with 5 % CO2 for 72 hours. Cells were stained with Giemsa and the number of syncytium, which contained more than 5 nuclei, was counted for each well. Three wells were used for each PBMC sample and the data were shown as an average of three wells. Flow Cytometry Total white blood cell (WBC) number was determined by automated cell counter (CelltacαMEK-6358, Nihon Kohden, Tokyo, Japan). The expression of cell surface antigen on white blood cells was determined by flow cytometry as previously reported.18 Monoclonal antibodies were used to determine the following cell surface antigens; CD3, CD4, CD8, CD335, WC1- N1, MHC class-ii, and CD14. The specificity and source of these antibodies are shown in Table 2. The surface antigen positive cell number was calculated based on the percentage of each antigen positive cell determined by flow cytometry (FACScan, Becton Dickinson, USA) and the total number of lymphocytes obtained from cell counter. Statistical Analysis Difference between two groups in syncytium number and leukocyte population for pre- and post-calving was determined using Mann-Whitney s U test. Difference in syncytium number and leukocyte population between pre- and post-calving for each group was analyzed using Wilcoxon rank sum test. P < 0.05 was considered significantly different. RESULTS There was no significant difference between two groups in pre-calving samples. Although the titer in Control Group did not differ between pre- and post-calving, Mastitis Group showed significant increase in virus titer after calving (Table 3). The numbers of CD3 +, CD4 +, and CD8 + T cells in Mastitis Group were significantly lower in pre-calving sampling compared to Control Group. After calving the number of CD335 + cells in Mastitis Group was signifi- Intern J Appl Res Vet Med Vol. 12, No. 3, 2014. 241

Table 3. Peripheral blood leukocyte profile and BLV syncytium. Mastitis Group (n=5) Control Group (n=11) Pre Post Pre Post WBC ( 100/μl) 147.00±24.49 126.60±27.33 151.36±18.56 142.27±22.22 PBMC ( 100/μl) 91.91±19.49 76.90±21.29 103.19±18.88 b 84.98±24.89 b Granulocytes ( 100/μl) 55.09±9.93 49.70±7.28 48.17±4.59 57.30±7.91 CD3 + ( 100/μl) 9.68±1.73* 9.11±1.84 16.24±1.62 b * 11.45±1.35 b CD4 + ( 100/μl) 2.98±0.53* 3.22±0.93 7.07±1.09 b * 4.65±0.41 b CD8 + ( 100/μl) 2.23±0.27* 2.50±0.62 4.39±0.62* 3.46±0.88 CD14 + ( 100/μl) 10.32±2.81 8.93±2.51 9.81±1.06 7.37±1.39 CD335 + ( 100/μl) 1.26±0.41 a 0.75±0.33a* 2.09±0.42 1.37±0.19* WC1-N1 + ( 100/μl) 2.81±0.80 2.04±0.72 3.84±0.51 b 2.72±0.36 b MHC class-ii+cd14- ( 100/μl) 70.80±21.14 a 52.58±19.92 a 75.76±18.49 62.77±24.08 Syncytium ( /well) 508.80±149.76 a 1478.20±426.62 a 550.64±156.55 525.73±233.49 cantly lower than that in Control Group. The numbers of PBMC, CD3 +, CD4 + T cells and WC1-N1 + cells in Control Group decreased significantly after calving compared to pre-calving samples. The number of CD335 + cells and MHC class-ii+cd14- cells in Mastitis Group decreased significantly after calving compared to that in precalving sample (Table 3). The percentage of CD4 + T cells in Mastitis Group were significantly lower in pre-calving sampling compared to Control Group. After calving the percentage of CD335 + cells in Mastitis Group was significantly lower than that in Control Group. The percentage of CD335 + cells in Mastitis Group decreased significantly after calving compared to that in pre-calving sample (Table 4). Although causes of five cows mastitis were variable, using Smirnov-Grubbs test in both precalving and post-calving Mastitis group, there was no outlier in the number of syncytium and population. DISCUSSION The objective of this study was to clarify the difference in BLV cows between with (Mastitis Group) and without (Control Group) mastitis during the periparturient period when immune function is suppressed. We focused on the difference in virus titer and leukocyte population in Mastitis Group and Control Group. Periparturient dairy cows have decreased number of T cells and their cytokine production skews toward Th2 type by expressing more mrna of IL-4 and IL-10. This may contribute to immunosuppression and makes cows more vulnerable to mastitis. 11,19 In the present 242 Vol. 12, No.3, 2014 Intern J Appl Res Vet Med.

Table 4. Percentage of peripheral blood mononuclear cell profile Mastitis Group (n=5) Control Group (n=11) Pre Post Pre Post CD3 + (%) 12.28±2.54 15.67±3.65 20.47±3.44 19.95±3.26 CD4 + (%) 3.37±0.43* 5.06±1.49 9.16±1.62* 8.76±1.61 CD8 + (%) 3.04±0.86 4.93±1.78 5.26±0.92 5.41±1.05 CD14 + (%) 16.48±7.76 14.44±3.59 11.89±1.94 13.92±2.95 CD335 + (%) 1.68±0.54 a 1.00±0.28 a * 2.24±0.33 2.32±0.34* WC1-N1 + (%) 3.61±1.03 3.06±0.84 4.39±0.66 4.75±0.78 MHC class-ii+cd14- (%) 69.28±10.46 59.81±9.08 65.09±5.37 60.65±6.15 Data are expressed as Mean±S.E. Pre: Precalving. Post: Postcalving. a,b: Significant difference between the same letters (P <0.05). *: Significant difference between groups (P <0.05). Mann-Whitney's U test and Wilcoxon rank sum test were used. study, Mastitis Group cows exhibited lower number of CD3+, CD4+, and CD8+ T cells compared to Control Group in the pre-calving samples. Decreased T cell number prior to calving might have increased susceptibility of cows to mastitis by reducing responsiveness of T cells to infection. We previously reported that BLV infected cows had higher number of B cells compared to non-blv at the time of parturition. Peripheral and mammary gland mononuclear cells of BLV infected cows expressed more IL-4 and IL-10 mrna after parturition compared to non-blv infected cows 9. IL-4 and IL-10 are known to mediate humoral immunity and suppress production of cytokines associated with cell-mediated immunity such as IL-12 and IFN-γ. 17 Domination of humoral immunity makes BLV cows more prone to progressing PL or EBL. 8 Cows with PL is reported to have reduced immune responsiveness and T cell function. 7 Thus periparturient BLV infected cows are more prone to develop mastitis as well as EBL. The number of B cells in the peripheral blood increases in BLV infected cows as the disease progresses. 15,20 Since B cells and monocytes express MHC class-ii in the peripheral blood, CD14-negative MHC class-ii positive cells are recognized as B cells. 1 The percentage of B cells among peripheral MHC class-ii positive cells from BLV infected cows has been shown to increase considerably more than uninfected cows. 3 In our previous study, clinically healthy BLV infected dairy cows showed high number of peripheral blood MHC class-ii+cd14- B cells,10 which was similar to the number of MHC class-ii+cd14- B cell in Control Group of the present study. There was no significant difference in MHC class- II+CD14- B cell number between Control Group and Mastitis Group. There was a possiblity that development of mastitis was not associated with the peripheral blood B cell number. Increase in BLV titer is associated with higher risk of BLV spreading. Especially periparturient dairy cows with BLV have lower antibody titer against BLV, thus increased shedding of virus into blood, milk, and other body fluid. 5 The syncytium number in the present study did not show significant difference between groups both at pre- and post-calving. However, Mastitis Group cows showed a significant increase in syncytium number after calving compared to pre-calving number. Mastitis Group cows had lower number of CD335 + NK cells after calving compared to Control Group. NK cells play an important role in the early stage of Intern J Appl Res Vet Med Vol. 12, No. 3, 2014. 243

immune response by killing virus or tumor cells using their cytotoxic ability as well as cytokine production. 2 NK cells indirectly respond to bacterial infection via activating macrophages and dendritic cells. 6 Decreased NK cell function is reported in HIV infected patients. 13 Therefore, Mastitis Group cows might have increased BLV in the peripheral blood due to lower cell mediated immunity of NK cells. In the present study, we found that BLV cows with lower number of T cells in the pre-calving period were prone to develop clinical mastitis after calving and increase in blood BLV titer thus risk of virus spreading. RFERENCES 1. Davis, W.C. and Larsen, R.M. 1989. Genetic markers identified by immunogenetic methods. Am. Fish. Soc. Symp. 7: 521-540. 2. Diefenbach, A. and Raulet, D.H. 2003. Innate immune recognition by stimulatory immunoreceptors. Curr. Opin. Immunol. 15: 37-44. 3. Erskine, R. J., Corl, C. M., Gandy, J. C. and Sordillo, L., M. 2011. Effect of infection bovine leucosis virus on lymphocyte proliferation and apoptosis in dairy cattle. Am. J. Vet. Res. 72: 1059-1064. 4. Gillet, N., Florins, A., Boxus, M., Burteau, C., Nigro, A., Vandermeers, F., Bolon, H. Bouzar, A., Defoiche, J., Burny, A., Reichert, M., Kettmann, R. and Willems, L. 2007. Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retovirology. 4: 18. 5. Hopkins, S. G. and DiGiacomo, R.F. 1997. Natural transmission of bovine leukemia virus in dairy and beef cattle. Vet. Clin. North Am. Food Anim. Pract. 13: 107-128. 6. Horowitz, A., Stegmann, K. A. and Riley, E. M. 2012. Activation of natural killer cells during microbial infections. Front. Immunol. 2: 1-13. 7. Ikebuchi, R., Konnai, S., Shirai, T., Sunden, Y., Murata, S., Onuma, M. and Ohashi, K. 2011. Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade. Vet. Res. 42: 1-15. 8. Kabeya, H., Ohashi, K. and Omuma, M. 2001. Host immune responses in course of bovine leukemia virus infection. J. Vet. Med. Sci. 63: 703-708. 9. Kakinuma, S., Maeda, Y., Ohtsuka, H., Ohmae, K., Ayabe, K., Konnai, S. and Oikawa, M. 2012. The leukocyte population in the peripheral blood and the colostrum of cows infected with bovine leukemia virus skewed towards humoral immunity. Intern. J. Appl. Res. Vet. Med. 10: 323-327. 10. Kakinuma, S., Ohtsuka, H., Ohmae, K., Ayabe, K., Kakinuma, M., Konnai, S. and Oikawa, M. 2011. Peripheral blood leukocyte populations in dairy cows infected with bovine leukemia virus. J. Jpn. Vet. Med. Assoc. 64: 375-380 (written in Japanese with English summary). 11. Kimura, K., Goff, J. P., Kehrli, M. E. Jr. and Harp, J. A. 1999. Phenotype analysis of peripheral blood mononuclear cells in periparturient dairy cows. J. Dairy Sci. 82: 315-319. 12. Konnnai, S., Usui, I., Ikeda, M., Kohara, J., Hirata, T., Okada, K., Ohashi, K. and Omuna, M. 2005. Imbalance of tumor necrosis factor receptors during progression in bovine leukemia virus infection. Viology. 339: 239-248. 13. Kottilil, S., Shin, K., Jackson, J. O., Reitano, K. N., O Shea, M. A., Yang, J., Hallahan, C. W., Lempicki, R., Arthos, J. and Fauci, A. S. 2006: Innate immune dysfunction in HIV infection: effect of HIV envelope-nk cell interactions. J. Immunol. 15: 1107-1114. 14. Małgorzata, S., Sławomir, Z. and Sylwia, K. 2012. Diagnosis of the bovine leukaemia virus infection in Polish Holstein-Friesian cows and comparison of their milk productivity. Acta Vet. Brno. 81: 353-358. 15. Mirsky, M. L., Da, Y. and Lewin, H. A. 1996. The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection. J. Virol. 70: 2178-2183. 16. Monti, G. E., Frankena, K. and DeJong, M. C. 2007. Evaluation of transmission of bovine leukemia virus with in dairy herds of Argentina. Epidemiol Infect. 135: 228-237. 17. Piccinni, M. P., Maggi, E. and Romagnani, S. 2000. Role of hormone-controlled T-cell cytokines in the maintenance of pregnancy. Biochem. Soc. Trans. 28: 212-215. 18. Riollet, C., Rainard, P. and Poutrel, B. 2001. Cell subpopulations and cytokine expression in cow milk in response to chronic Staphylococcus aureus infection. J. Dairy Sci. 84: 1077-1084. 19. Shafer-Weaver, K. A., Corl, C. M. and Sordillo, L. M. 1999. Shifts in bovine CD4+ subpopulations increase T-helper-2 compared with T-helper-1 effector cells during the postpartum period. J. Dairy Sci. 82: 1696-1706. 20. Shwartz, I. and Levy, D. 1994. Pathobiology of bovine leukemia virus. Vet. Res. 25: 521-536. 21. Trainin, Z., Brenner, J., Meirom, R. and Ungar- Waron, H. 1996. Detrimental effect of bovine leukemia virus (BLV) on the immunological state of cattle. Vet. Immunol. Immunopathol. 54: 293-302. 22. Wellenberg, G. J., van der Poel, W. H. M. and van Oirschot, J. T. 2002. Viral infections and bovine mastitis: a review. Vet. Micobiol. 88: 27-45. 23. Yoshikawa, H., Xie, B., Oyamada, T., Hiraga, A. and Yoshikawa, T. 1997. Detection of bovine leukemia viruses (BLV) in mammary tissues of BLV antibody-positive cows affected by subclinical mastitis. J. Vet. Med. Sci. 59: 301-302. 244 Vol. 12, No.3, 2014 Intern J Appl Res Vet Med.